Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:DN CVE:FLWR CVE:KHRN CVE:MPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDNDelta 9 CannabisC$0.00C$0.01▼C$0.07C$3.02M1.21813,175 shs1.07 million shsFLWRFlowrC$0.03C$0.02C$0.02▼C$0.11C$10.66MN/A302,866 shs29,006 shsKHRNKhiron Life SciencesC$0.04C$0.04C$0.04▼C$0.21C$9.30M2.64256,268 shs24,000 shsMPHMedicureC$1.00-10.7%C$1.15C$0.63▼C$1.33C$10.44M1.0737644,582 shs15,500 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDNDelta 9 Cannabis0.00%0.00%0.00%0.00%0.00%FLWRFlowr0.00%0.00%0.00%0.00%0.00%KHRNKhiron Life Sciences0.00%0.00%0.00%0.00%0.00%MPHMedicure-10.71%-10.71%-13.04%-5.66%-0.99%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDNDelta 9 CannabisC$0.00C$0.01▼C$0.07C$3.02M1.21813,175 shs1.07 million shsFLWRFlowrC$0.03C$0.02C$0.02▼C$0.11C$10.66MN/A302,866 shs29,006 shsKHRNKhiron Life SciencesC$0.04C$0.04C$0.04▼C$0.21C$9.30M2.64256,268 shs24,000 shsMPHMedicureC$1.00-10.7%C$1.15C$0.63▼C$1.33C$10.44M1.0737644,582 shs15,500 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDNDelta 9 Cannabis0.00%0.00%0.00%0.00%0.00%FLWRFlowr0.00%0.00%0.00%0.00%0.00%KHRNKhiron Life Sciences0.00%0.00%0.00%0.00%0.00%MPHMedicure-10.71%-10.71%-13.04%-5.66%-0.99%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDNDelta 9 Cannabis 0.00N/AN/AN/AFLWRFlowr 0.00N/AN/AN/AKHRNKhiron Life Sciences 0.00N/AN/AN/AMPHMedicure 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDNDelta 9 CannabisC$70.65M0.00N/A4.47C($0.04) per share0.00FLWRFlowrC$12.92M0.83C$0.00 per share8.33C$0.00 per share-25.00KHRNKhiron Life SciencesC$18.08M0.51C$0.01 per share6.67C$0.20 per share0.20MPHMedicureC$23.20M0.45C$0.40 per share2.49C$1.91 per share0.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDNDelta 9 Cannabis-C$19.60M-C$0.10N/AN/AN/A-27.74%-29,673.63%-12.08%N/AFLWRFlowrN/A-C$0.21N/A∞N/AN/AN/AN/AN/AKHRNKhiron Life Sciences-C$46.80M-C$0.20N/A∞N/A-258.92%-68.62%-20.79%N/AMPHMedicure-C$2.03M-C$0.13N/A∞N/A-9.65%-10.18%-5.63%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDNDelta 9 CannabisN/AN/AN/AN/AN/AFLWRFlowrN/AN/AN/AN/AN/AKHRNKhiron Life SciencesN/AN/AN/AN/AN/AMPHMedicureN/A2.24%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDNDelta 9 Cannabis2,156.190.300.14FLWRFlowr71.271.130.15KHRNKhiron Life Sciences6.683.080.72MPHMedicure4.652.031.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDNDelta 9 CannabisN/AFLWRFlowrN/AKHRNKhiron Life Sciences0.22%MPHMedicure4.85%Insider OwnershipCompanyInsider OwnershipDNDelta 9 Cannabis14.51%FLWRFlowrN/AKHRNKhiron Life Sciences4.64%MPHMedicure26.68%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDNDelta 9 Cannabis200302.18 millionN/ANot OptionableFLWRFlowr186426.47 millionN/ANot OptionableKHRNKhiron Life SciencesN/A232.41 millionN/ANot OptionableMPHMedicureN/A10.44 millionN/ANot OptionableDN, MPH, FLWR, and KHRN HeadlinesRecent News About These CompaniesMedicure Second Quarter 2025 Earnings: CA$0.08 loss per share (vs CA$0.12 loss in 2Q 2024)August 22, 2025 | finance.yahoo.comMedicure Inc. Reports Increased Revenue and Improved EBITDA for Q2 2025August 20, 2025 | tipranks.comMedicure to Present Financial Results on August 21…August 20, 2025 | pharmiweb.comPMedicure Inc. to Announce Q2 2025 Financial ResultsAugust 18, 2025 | tipranks.comMedicure, Inc.: Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia PharmacyJune 17, 2025 | finanznachrichten.deEarnings call transcript: Medicure reports Q1 2025 decline in revenue, steady stockMay 24, 2025 | uk.investing.comMedicure, Inc.: Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical PharmacyMarch 11, 2025 | finanznachrichten.deTyreek Hill was driving an estimated 60 mph in a 40 mph zone before hectic detainment incidentSeptember 12, 2024 | nypost.comNMedicure Inc. (NGQ1.F)August 21, 2024 | uk.finance.yahoo.comMedicure Inc. (MPH.V)August 12, 2024 | ca.finance.yahoo.comMPH:CA Medicure Inc.July 26, 2024 | seekingalpha.comPublic Health (Health Services Administration) MPHMay 25, 2024 | buffalo.eduBMaster of Public Health in Social and Behavioral SciencesMay 12, 2024 | uml.eduURochester, United States - Weather Forecasts | Maps | News - Yahoo WeatherMay 5, 2024 | yahoo.comCluj-Napoca, Romania - Weather Forecasts | Maps | News - Yahoo WeatherApril 24, 2024 | yahoo.comMedicure, Inc.: Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO DeficiencyApril 23, 2024 | finanznachrichten.deLiverpool, United Kingdom - Weather Forecasts | Maps | News - Yahoo WeatherApril 22, 2024 | yahoo.comSofia, Bulgaria - Weather Forecasts | Maps | News - Yahoo WeatherApril 21, 2024 | yahoo.comDallas, United States - Weather Forecasts | Maps | News - Yahoo WeatherApril 19, 2024 | yahoo.comPrescott, United States - Weather Forecasts | Maps | News - Yahoo WeatherApril 18, 2024 | yahoo.comMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025Workday: Institutions Are Buying This Stock, Shouldn’t You?By Thomas Hughes | August 23, 20253 Cheap Stocks That Shouldn't Be This LowBy Gabriel Osorio-Mazilli | August 25, 2025Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tBy Thomas Hughes | September 8, 2025DN, MPH, FLWR, and KHRN Company DescriptionsDelta 9 Cannabis TSE:DNDelta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. The company was incorporated in 2001 and is based in Vancouver, Canada.Flowr CVE:FLWRC$0.02 0.00 (0.00%) As of 10/17/2022The Flowr Corporation cultivates, produces, and sells cannabis in Canada. The company offers dried flowers and pre-rolls. It also has operations in Canada, Portugal, and the European Union. The company was incorporated in 2016 and is headquartered in Toronto, Canada.Khiron Life Sciences CVE:KHRNC$0.04 0.00 (0.00%) As of 05/5/2023Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.Medicure CVE:MPHC$1.00 -0.12 (-10.71%) As of 09/12/2025 03:44 PM EasternMedicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
